How do AD patients and their caregivers decide whether to enroll in a clinical trial?

Neurology

Volumn 56, Issue 6, 2001, Pages 789-792

  Karlawish, Jason H T ^a,b,c,d,f   Casarett, David ^a,b,d,e,f   Klocinski, Jennifer ^a   Sankar, Pamela ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Division of Geriatrics   (United States)

^c Alzheimer's Disease Center   (United States)

^d Center for Bioethics   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Institute on Aging   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CLINICAL RESEARCH; DECISION MAKING; HUMAN; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0035957250     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.6.789     Document Type: Article

References (6)

1. Research on the cognitively impaired: Lessons and warnings from the Emergency Research Debate
2. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
3. The fragile foundation of contemporary biomedical research
4. Participation in clinical trials and long-term outcomes in Alzheimer's disease